This topic contains a solution. Click here to go to the answer

Author Question: Collusion among firms to raise price is rare in monopolistically competitive markets because a. ... (Read 18 times)

rlane42

  • Hero Member
  • *****
  • Posts: 594
Collusion among firms to raise price is rare in monopolistically competitive markets because
 a. there are too many firms
  b. there are too few firms
  c. there is only one firm
  d. products are homogeneous
  e. price leadership is used instead

Question 2

Which of the following did not contribute to the increase in competition in the United States between 1958 and 1988?
 a. antitrust activity
  b. deregulation of transportation industries
  c. deregulation of banking
  d. increased imports
  e. conglomerate mergers



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

yasmina

  • Sr. Member
  • ****
  • Posts: 323
Answer to Question 1

A

Answer to Question 2

E




rlane42

  • Member
  • Posts: 594
Reply 2 on: Jun 30, 2018
Excellent


meow1234

  • Member
  • Posts: 333
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Interferon was scarce and expensive until 1980, when the interferon gene was inserted into bacteria using recombinant DNA technology, allowing for mass cultivation and purification from bacterial cultures.

Did you know?

Aspirin may benefit 11 different cancers, including those of the colon, pancreas, lungs, prostate, breasts, and leukemia.

Did you know?

The effects of organophosphate poisoning are referred to by using the abbreviations “SLUD” or “SLUDGE,” It stands for: salivation, lacrimation, urination, defecation, GI upset, and emesis.

Did you know?

Intradermal injections are somewhat difficult to correctly administer because the skin layers are so thin that it is easy to accidentally punch through to the deeper subcutaneous layer.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library